Biohybrids of Anoxia-Targeted Bacteria/MDPP for Enabling Targeted Synergistic Immunotherapy and Chemotherapy Against Breast Tumors
International Journal of Nanomedicine · 2025
DOI: 10.2147/ijn.s515213 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2025. Verfasst von Tian Hu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China. Hauptthemen laut MEDLINE: Breast Neoplasms, Immunotherapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
The hypoxic tumor microenvironment (TME) significantly impacts the effectiveness of various therapies on breast cancer. Conventional chemotherapeutic agents are unable to target hypoxic tumor tissue specifically, leading to reduced treatment efficacy and severe systemic toxicity. In order to improve drug targeting ability, we developed a bioactive biomotors system (MDPP@Bif) for chemoimmunotherapy against breast cancer. Utilizing the self-driving properties of the anaerobic Bifidobacterium infantis (B. infantis, Bif), both doxorubicin (DOX) and anti-programmed cell death protein ligand-1 (αPD-L1) antibody can be delivered simultaneously to tumor tissues to exert an anti-tumor effect on breast cancer.
Methods
The physicochemical properties of diverse nano-formulations were systematically characterized. In vitro anti-tumor efficacy of the MDPP@Bif biomotors was assessed through comprehensive biological evaluations, including 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays, live/dead staining, c cellular uptake analysis, apoptosis quantification, and wound healing assays to evaluate the in vitro anti-tumor activity of the MDPP@Bif biomotors. Furthermore, the therapeutic potential of the MDPP@Bif biohybrids was validated in vivo using a murine breast cancer model by monitoring of tumor growth kinetics, body weight fluctuations, and survival outcomes. Immunofluorescence staining was also used to further validate T-cells infiltration in the tumor tissues.
Results
The developed MDPP@Bif biomotors can actively colonize hypoxic tumor tissues through Bif's inherent targeting ability, releasing DOX to inhibit tumor growth. The released αPD-L1 antibody specifically binds to PD-L1, reducing immune escape and activating T cells. The concentration of DOX in tumor tissues of the MDPP@Bif group was 2.5 times higher than in tumors treated with free DOX, significantly prolonging the median survival of mice to 62 days and reducing the toxic side effects of DOX.
Conclusion
The novel bacteria-propelled biomotor MDPP@Bif shows great potential in treating solid tumors through synergistic chemotherapy and immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China.
- Department of Oncology, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China.
- Department of Radiology, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China.
- Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, Sichuan, 646000, People's Republic of China.
ORCID-Profile: Shaozhi Fu
Zitieren
APA
Hu, T., Zhang, L., Lu, Y., Xiong, K., Wen, Q., Huang, J., Deng, H., Xiang, K., Zhou, P., & Fu, S. (2025). Biohybrids of Anoxia-Targeted Bacteria/MDPP for Enabling Targeted Synergistic Immunotherapy and Chemotherapy Against Breast Tumors. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s515213
Vancouver
Hu T, Zhang L, Lu Y, Xiong K, Wen Q, Huang J, et al. Biohybrids of Anoxia-Targeted Bacteria/MDPP for Enabling Targeted Synergistic Immunotherapy and Chemotherapy Against Breast Tumors. International Journal of Nanomedicine. 2025. doi:10.2147/ijn.s515213
BibTeX
@article{Hu2025,
author = {Hu, Tian and Zhang, Linsong and Lu, Yun and Xiong, Kang and Wen, Qian and Huang, Jingrong and Deng, Hongjun and Xiang, Kewei and Zhou, Ping and Fu, Shaozhi},
title = {Biohybrids of Anoxia-Targeted Bacteria/MDPP for Enabling Targeted Synergistic Immunotherapy and Chemotherapy Against Breast Tumors},
journal = {International Journal of Nanomedicine},
year = {2025},
doi = {10.2147/ijn.s515213}
}
EUVIMED